| February 2006 |
|
|
Grassley Questions FDA’s Sanction of Blood Substitute Study Without Patient Consent
|
|
|
Grassley Calls Political Exploitation of Medicare Drug Benefit “Unconscionable
|
|
|
Grassley Questions UAE Ports Deal, Potential Impact on National, Trade Security
|
|
|
Senator Grassley's Statement for the Record regarding FDA's Approval Process
|
|
|
Grassley Decries Democratic Leaders’ Political Hypocrisy on Medicare
|
|
|
Grassley Says Report Shows Trade Assistance Program Helps Workers
|
|
|
Grassley: Closing Tax Gap Will Require More Hard Work
|
|
|
Grassley: Democratic Leaders Lose Ground on Tax Relief
|
|
|
Grassley Weighing Options to Enhance U.S.-China Trade Relationship
|
|
|
Grassley, Baucus Say Oregon Death Raises Safety Concerns at Specialty Hospitals Question HHS on Hospital Approval, Oversight
|
|
|
Grassley Questions Repeated Delays of Popular Tax Relief
|
|
|
Grassley: Congress Unlikely to Revisit FSC-ETI Bill, Europe Should Recognize U.S. Effort
|
|
|
Grassley Pursues Details of Patient Protections, Standards at Drug Testing Company
|
|
|
Grassley Highlights Unexpected FDA Panel Move on Attention Deficit Medicines
|
|
|
Grassley to Convene Hearing to Examine Administration’s Trade Agenda
|
